申请人:Pharmacia AB
公开号:US04628083A1
公开(公告)日:1986-12-09
The invention relates to new arylazo compounds of the general formula ##STR1## wherein R.sub.1 and R.sub.2 independently of each other represent hydrogen or C.sub.1-3 alkyl, R.sub.3 represents hydrogen, halogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, carboxy, C.sub.1-3 alkoxycarbonyl, C.sub.1-3 alkylcarbonyl or a group X--NH--SO.sub.2 --, wherein X represents a heterocyclic ring, R.sub.4 represents hydrogen, halogen or C.sub.1-3 alkyl, and n is the integer 1 or 2, the two groups ##STR2## being the same or different when n is 2, and lactones and salts thereof. The compounds of formula I have a high inhibiting effect on prostaglandin synthetizing and inactivating enzymes and may therefore be used as a drug and anti-fertility agent. The invention also relates to preparation of the compounds of formula I as well as pharmaceutical compositions containing the same.
本发明涉及一种新的芳基偶氮化合物,其一般式为##STR1##其中R.sub.1和R.sub.2独立地表示氢或C.sub.1-3烷基,R.sub.3表示氢、卤素、C.sub.1-3烷基、C.sub.1-3烷氧基、羧基、C.sub.1-3烷氧羰基、C.sub.1-3烷基羰基或X--NH--SO.sub.2 --基团,其中X表示杂环,R.sub.4表示氢、卤素或C.sub.1-3烷基,n是整数1或2,当n为2时,两个##STR2##基团相同或不同,以及其内酯和盐。公式I的化合物对前列腺素合成和失活酶具有高抑制作用,因此可用作药物和抗生育药剂。本发明还涉及公式I的化合物的制备以及含有它们的制药组合物。